Impact of myeloid differentiation protein 1 on cardiovascular disease

Xiaobo Jiang1, Peng Ning2, Fang Yan3

  • 1Geriatric Diseases Institute of Chengdu, Department of Cardiology, Chengdu Fifth People's Hospital, Chengdu 611137, China; The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Insights

Myeloid differentiation protein 1 (MD1) is crucial in cardiovascular disease. Reduced MD1 levels are linked to cardiac remodeling and poor outcomes, suggesting its potential as a therapeutic target.

Area of Science:

  • Cardiovascular Pathophysiology
  • Molecular Mechanisms of Cardiac Remodeling
  • Inflammation and Immune Response in Heart Disease

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of global mortality, characterized by complex cardiac remodeling.
  • Cardiac remodeling involves reactive oxygen species (ROS) and inflammation, contributing to heart failure and sudden cardiac death (SCD).
  • Myeloid differentiation protein 1 (MD1), a component of the MD1-RP105 complex, regulates inflammation and vascular remodeling.

Purpose of the Study:

  • To review the current understanding of Myeloid differentiation protein 1 (MD1)'s role in cardiovascular pathophysiology.
  • To explore the potential clinical significance of MD1 in cardiovascular diseases.

Main Methods:

  • Literature review of studies investigating MD1 in the context of cardiovascular disease.
  • Analysis of existing research on MD1's involvement in inflammation and cardiac remodeling pathways.

Main Results:

  • Evidence suggests MD1 expression is decreased in hypertrophic cardiomyopathy (HCM) patients compared to controls.
  • The MD1-RP105 complex is implicated in modulating vascular remodeling and atherosclerotic plaque development.
  • Reduced MD1 may contribute to pathological cardiac remodeling processes.

Conclusions:

  • Myeloid differentiation protein 1 (MD1) plays a significant role in regulating cardiac pathophysiology.
  • Decreased MD1 levels are associated with cardiovascular disease, particularly HCM.
  • MD1 holds potential as a biomarker or therapeutic target for cardiovascular diseases.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
22
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
65